Silk Road Medical, Inc (NASDAQ:SILK) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Silk Road Medical, Inc (NASDAQ: SILK) had its price target raised by analysts at JPMorgan Chase & Co. from $19.00 to $21.00. They now have a "neutral" rating on the stock.
Silk Road Medical, Inc (NASDAQ: SILK) had its price target raised by analysts at Piper Sandler from $18.00 to $20.00. They now have a "neutral" rating on the stock.
Silk Road Medical Reports First Quarter 2024 Financial Results [Yahoo! Finance]
Silk Road Medical Reports First Quarter 2024 Financial Results